Skip to main content

Basel Medical Group Ltd

BMGL
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0002004489

No open-market purchases or sales by Basel Medical Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $3.44K in total; no superinvestor holds it.

Holders of 5% or more of BMGL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Basel Medical Group Ltd, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of BMGL
HolderLatest formStakeChangeFirst filedLatest filingFiling
Rainforest Capital VCC13G54.20%10.2M sharesNewApr 30, 20251 filingApr 30, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

1 Schedule 13D or 13G filing on Basel Medical Group Ltd, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BMGL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Apr 30, 20256:15 AM ETRainforest Capital VCCand 2 others13G54.20%10.2M sharesNewFeb 21, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Basel Medical Group Ltd shares.

No Form 144 notices for Basel Medical Group Ltd are on file.